Summary
Bristol Myers Squibb Co. (BMY) filed its Form 10-Q for the quarterly period ending June 29, 1996. This filing provides a snapshot of the company's financial performance and position during this period. Investors should note that as this is a historical filing from 1996, it reflects a business environment and product landscape significantly different from today. The information presented is crucial for understanding the company's historical trajectory and can be used as a baseline for evaluating its long-term growth and strategic decisions made in the mid-1990s. While specific financial metrics and segment performance details are not provided in the provided filing excerpt, typical 10-Q filings would include detailed financial statements, management's discussion and analysis (MD&A) of financial condition and results of operations, and disclosures on legal proceedings and risk factors. Investors interested in BMY's performance during this quarter would need to access the full report to gain comprehensive insights into revenue, profitability, debt levels, and any significant operational developments.
Key Highlights
- 1Company: Bristol Myers Squibb Co. (BMY)
- 2Filing Type: Quarterly Report (10-Q)
- 3Period End Date: June 29, 1996
- 4Filing Date: August 13, 1996
- 5The filing represents a historical financial update from the mid-1990s.
- 6Specific financial data and operational details are not detailed in the provided excerpt, requiring access to the full report for in-depth analysis.